This is unsurprising since oncogenesis requires multiple mutations including both oncogene induction and tumor suppressor attenuation." Description DIHEXA Synthetic is a single, non-glycosylated polypeptide chain containing 3 amino acids, having a molecular mass of 504.28 Dalton and a Molecular formula of C 27 H 44 N 4 O 5.
Although research on intranasal administration of BPC-157 is extremely limited, broad studies on the potential benefits of intranasally administered peptide therapeutics suggest that this may be a beneficial RoA [11, 12]
It appears more selective and possibly safer than older senolytic approaches
April 23, 2026: Amend Management Agreement and Service Assessment Plan Council approved updates to the Citys management agreement with the DAA for DPID services (Council Item #11) and to the DAAs FY202627 Service and Assessment Plan and Budget (Council Item #12)
Side Effects and Precautions Known Risks (Animal Studies + Anecdotal Reports) Potential for over-stimulation of neurogenesis , which is beneficial short-term but may carry unknown long-term risks Some users report: Mild headaches Irritability or emotional blunting Temporary insomnia if taken late in the day Theoretical Risk: Tumor Growth